Clinical trials, pathologies and developments in personalized medicine
Francesco d'Amore et al.
Panobinostat and donor lymphocyte infusions in patients with high-risk AML and MDS
HARMONY: a collaboration between 51 partners
Why it is important to individualize care for multiple myeloma patients
Bispecific agents: the future of AML and MDS treatment?